2nd Quarter - Report
NVG, LLC for PHRMA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Counterfeit Drug Penalty Enhancement Act of 2011(HR 3668, S 1886)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Health Issues HCR
FDA user fee program reauthorization; Fair And Immediate Release of Generic Drugs Act (S. 1882)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.